Tuesday, July 9, 2019
UNT conference to feature the latest in autism intervention, research
Monday, July 1, 2019
UNT Professor invents detector for credit card skimmers
Tuesday, June 25, 2019
U.S. Department of State grant creates new partnership between UNT and institutions in Mexico
Tuesday, June 25, 2019
UNT behavioral science assistant professor receives Powe award for work in stroke assessment research
Thursday, June 20, 2019
UNT engineering team joins NASA challenge to improve life support for astronauts
Tuesday, June 18, 2019
UNT Sub-Antarctic Biocultural Conservation Program and Director Ricardo Rozzi earn top honors for work in Chile
Monday, June 17, 2019
Texas legislature gives $10 million boost to UNT’s Center for Agile and Adaptive Additive Manufacturing
DENTON (UNT), Texas — Imagine transforming manufacturing technologies to better develop complex 3-D objects to create viable market-based solutions that impact almost every industry from operating rooms to oil fields — all while producing practically zero waste and cost savings that give Texas’ companies an advantage.
That’s exactly what the University of North Texas’ Center for Agile and Adaptive Additive Manufacturing intends to do with $10 million in...
Thursday, June 6, 2019
UNT researcher rediscovers decades old solution to a modern problem
University of North Texas BioDiscovery Institute Research Associate Jaime Barros recently authored a paper published in the journal Nature Communications that utilizes state-of-the-art techniques to confirm 40-year-old research explaining how plants produce lignin, a compound that provides structural rigidity in plants and allows them to grow upright.
“Understanding how lignin is produced in plants also means that it can be manipulated...
Friday, May 31, 2019
UNT statistician develops risk prediction model for childhood cancer survivors to avoid anthracycline-related cardiomyopathy
University of North Texas associate professor Xuexia “Helen” Wang first noticed a correlation between anthracycline, a class of chemotherapy drugs used to treat cancer patients, and cardiomyopathy, a type of heart disease, in childhood cancer survivors when she worked as a researcher for City of Hope in 2010.
Since then, she has dedicated her career to better understanding cancer, cancer-treatments and the side effects.
“Childhood cancer survivors are at a five- to 15-fold increased risk of anthracycline-related cardiomyopathy,...